secwatch.observer — SEC 8-K summary
======================================

Issuer:     Passage BIO, Inc. (PASG)
CIK:        0001787297
Form:       8-K
Filed at:   2026-05-26T11:15:24+00:00
Accession:  0001104659-26-065991
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Passage Bio stockholders elect two Class III directors, ratify KPMG, approve say-on-pay
--------------------------------------------------------------------------------

- Athena Countouriotis and Sandip Kapadia elected as Class III directors for three-year terms.
- KPMG LLP ratified as independent auditor for FY2026 (2,083,031 for, 41,539 against).
- Non-binding advisory vote on executive compensation approved (1,452,505 for, 36,352 against).
- Stockholders favored holding say-on-pay vote every year; board adopts annual frequency policy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787297/000110465926065991/0001104659-26-065991-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787297/000110465926065991/tm2615548d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-065991

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer